88 related articles for article (PubMed ID: 25280290)
1. Re: body fat content and distribution and urinary risk factors for nephrolithiasis.
Assimos DG
J Urol; 2014 Jun; 191(6):1811. PubMed ID: 25280290
[No Abstract] [Full Text] [Related]
2. Body fat content and distribution and urinary risk factors for nephrolithiasis.
Pigna F; Sakhaee K; Adams-Huet B; Maalouf NM
Clin J Am Soc Nephrol; 2014 Jan; 9(1):159-65. PubMed ID: 24202136
[TBL] [Abstract][Full Text] [Related]
3. Effect of diclofenac-Na on 24-hour urinary excretion of creatinine, calcium, uric acid and glycosaminoglycans in adult patients with recurrent calcium oxalate nephrolithiasis.
Hemal AK; Sidhu H; Thind SK; Nath R; Vaidyanathan S
Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):44-6. PubMed ID: 2744906
[TBL] [Abstract][Full Text] [Related]
4. Uric acid/calcium oxalate nephrolithiasis. Clinical and biochemical findings in 86 patients.
Rapado A; Castrillo JM; Diaz-Curiel M; Traba ML; Santos M; Cifuentes-Delatte L
Adv Exp Med Biol; 1980; 122A():109-13. PubMed ID: 7424622
[No Abstract] [Full Text] [Related]
5. The role of glycosaminoglycans and uric acid in idiopathic calcium nephrolithiasis.
Baggio B; Gambaro G; Marchi A; Cicerello E; Favaro S; Borsatti A
Contrib Nephrol; 1984; 37():5-8. PubMed ID: 6713879
[No Abstract] [Full Text] [Related]
6. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
[TBL] [Abstract][Full Text] [Related]
7. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
Eisner BH; Eisenberg ML; Stoller ML
Urology; 2010 Jun; 75(6):1289-93. PubMed ID: 20018350
[TBL] [Abstract][Full Text] [Related]
8. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
[TBL] [Abstract][Full Text] [Related]
9. [Physiopathological diagnosis of changes in uric acid metabolism: hyperuricuria and nephrolithiasis].
García Puig J; Mateos Antón F; Ramos T
Med Clin (Barc); 1987 Sep; 89(8):339-47. PubMed ID: 3320609
[No Abstract] [Full Text] [Related]
10. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis.
Sakhaee K; Adams-Huet B; Moe OW; Pak CY
Kidney Int; 2002 Sep; 62(3):971-9. PubMed ID: 12164880
[TBL] [Abstract][Full Text] [Related]
11. [Nephrolithiasis--correlation of calculus type and pathogen spectrum. Calculus analysis and microbiologic diagnosis in 173 surgically treated patients].
Friesen A; Stern J; Hofstetter AG; Schilling A
Fortschr Med; 1984 Nov; 102(43):1109-12. PubMed ID: 6392048
[TBL] [Abstract][Full Text] [Related]
12. [Effect of proteolytic enzymes, electrolytes and other factors on the crystallization of calcium oxalate in the urine].
Börner RH; Brundig P; Mäurer F; Berg W; Baumann W
Z Urol Nephrol; 1983 May; 76(5):327-31. PubMed ID: 6224367
[TBL] [Abstract][Full Text] [Related]
13. [Metabolic syndrome and nephrolithiasis].
Kohjimoto Y; Iba A; Sasaki Y; Hara I
Hinyokika Kiyo; 2011 Jan; 57(1):43-7. PubMed ID: 21304261
[TBL] [Abstract][Full Text] [Related]
14. Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary?
Cicerello E; Mangano M; Cova GD; Merlo F; Maccatrozzo L
Arch Ital Urol Androl; 2016 Oct; 88(3):208-211. PubMed ID: 27711095
[TBL] [Abstract][Full Text] [Related]
15. [Nephrolithiasis of adult: From mechanisms to preventive medical treatment].
Courbebaisse M; Prot-Bertoye C; Bertocchio JP; Baron S; Maruani G; Briand S; Daudon M; Houillier P
Rev Med Interne; 2017 Jan; 38(1):44-52. PubMed ID: 27349612
[TBL] [Abstract][Full Text] [Related]
16. Effect of dietary control of urinary uric acid excretion in calcium oxalate stone formers and non-stone-forming controls.
Pais VM; Holmes RP; Assimos DG
J Endourol; 2007 Feb; 21(2):232-5. PubMed ID: 17338626
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
Pak CY; Peterson R
Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
[TBL] [Abstract][Full Text] [Related]
18. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery.
Sinha MK; Collazo-Clavell ML; Rule A; Milliner DS; Nelson W; Sarr MG; Kumar R; Lieske JC
Kidney Int; 2007 Jul; 72(1):100-7. PubMed ID: 17377509
[TBL] [Abstract][Full Text] [Related]
19. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
[TBL] [Abstract][Full Text] [Related]
20. Proportional reduction of urine supersaturation during nephrolithiasis treatment.
Coe FL; Wise H; Parks JH; Asplin JR
J Urol; 2001 Oct; 166(4):1247-51. PubMed ID: 11547051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
